NCT06769880 Use of Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Failure in the Emergency Department
| NCT ID | NCT06769880 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rush University Medical Center |
| Condition | Heart Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-10-13 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-10-13 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if using point-of-care ultrasound (POCUS) can increase participant engagement and changes in behavior among adults with risk factors for pre-symptomatic heart failure presenting to the emergency department. The main questions it aims to answer are: 1. Does POCUS increase understanding of heart failure and the likelihood to improve diet, exercise, and follow up? 2. Does POCUS improve diet, exercise, follow up, and self-efficacy at three months post-intervention? Researchers will compare an educational intervention with versus without POCUS to see if POCUS works to improve outcomes. Participants will: Receive either the educational intervention alone or an educational intervention plus POCUS. They will report the difference in their understanding and likelihood to improve diet, exercise, and follow up immediately post-intervention. They will also report changes in diet, exercise, follow up, and self-efficacy at three months post-intervention.
Eligibility Criteria
Inclusion Criteria: * Must be 45 years of age or older * Must have high blood pressure, diabetes mellitus, or obesity (body mass index ≥30 kg/m2) Exclusion Criteria: * Symptoms of acute heart failure (difficulty breathing, leg swelling) * History of heart failure * Unable to tolerate an ultrasound examination * No access to a phone for follow up
Contact & Investigator
Michael Gottlieb, MD
PRINCIPAL INVESTIGATOR
Rush University Medical Center
Frequently Asked Questions
Who can join the NCT06769880 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, studying Heart Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06769880 currently recruiting?
Yes, NCT06769880 is actively recruiting participants. Contact the research team at aylin_a_ornelasloredo@rush.edu for enrollment information.
Where is the NCT06769880 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06769880 clinical trial?
NCT06769880 is sponsored by Rush University Medical Center. The principal investigator is Michael Gottlieb, MD at Rush University Medical Center. The trial plans to enroll 100 participants.